MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation study of Parkinson anxiety scale, Czech version

N. Zemanová, M. Baláz (Brno, Czech Republic)

Meeting: 2016 International Congress

Abstract Number: 379

Keywords: Non-motor Scales, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The study aims to evaluate psychometric properties of Czech version of Parkinson Anxiety Scale (PAS), new scale developed in 2014 to measure anxiety specifically in Parkinson´s disease.

Background: Anxiety disturbances remains under-recognized non-motor symptom of PD, moreover the research is limited by lack of anxiety rating scales validated for Parkinsonian population. Original version of PAS offers better psychometric properties than existing anxiety scale. Appropriate validation study and language adaptation is necessary for further research and clinical practice in Czech Republic.

Methods: Patients with idiopathic PD (40) underwent a standardized assessment including a structured interview for presence of DSM-defined depressive and anxiety disorders (M.I.N.I; mini international neuropsychiatric inventory; NPI, version 5.0.0), Hamilton Anxiety Rating Scale (HARS), Beck Anxiety Inventory (BAI), PAS and Beck Depression Inventory (BDI). Demographic and disease related variables (UPDRS, Hoehn & Yahr, PD duration and L-Dopa medication) were registered, assessment of cognitive functions was done with MMSE a Mattis Dementia Rating Scale.

Results: Eleven patients (27%) suffered from an anxiety disorder according to NPI, however additional 22% of patients had symptoms of anxiety in the absence of anxiety disorder diagnosis with NPI. Less than 0.01% missing data shows good acceptability, internal consistency coefficient was very satisfying for full scale (0.89) as well as for three subscales (0.87; 0.75 and 0.66). The concurrent validity was also supported by significant correlation with HARS (0.89) and BAI (0.86). However, test-retest reliability did not met expected criteria (0.68).

Conclusions: Despite the limited sample size, our data demonstrate that PAS proved to be reliable and valid anxiety measure in the PD and will stimulate further research of anxiety in PD.

To cite this abstract in AMA style:

N. Zemanová, M. Baláz. Validation study of Parkinson anxiety scale, Czech version [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/validation-study-of-parkinson-anxiety-scale-czech-version/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-study-of-parkinson-anxiety-scale-czech-version/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley